Overbrook Management Corp’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-415
Closed -$110K 85
2022
Q2
$110K Hold
415
0.03% 85
2022
Q1
$125K Hold
415
0.03% 92
2021
Q4
$146K Hold
415
0.03% 97
2021
Q3
$106K Hold
415
0.02% 87
2021
Q2
$276K Hold
415
0.06% 81
2021
Q1
$360K Hold
415
0.08% 65
2020
Q4
$385K Hold
415
0.09% 65
2020
Q3
$426K Hold
415
0.1% 83
2020
Q2
$420K Hold
415
0.11% 83
2020
Q1
$360K Hold
415
0.16% 51
2019
Q4
$445K Hold
415
0.13% 55
2019
Q3
$383K Hold
415
0.1% 61
2019
Q2
$469K Hold
415
0.1% 56
2019
Q1
$564K Hold
415
0.12% 54
2018
Q4
$480K Hold
415
0.11% 54
2018
Q3
$630K Sell
415
-4
-1% -$6.16K 0.12% 55
2018
Q2
$655K Hold
419
0.12% 52
2018
Q1
$484K Hold
419
0.1% 55
2017
Q4
$496K Sell
419
-25
-6% -$31.3K 0.1% 57
2017
Q3
$597K Sell
444
-1,645
-79% -$1.73M 0.13% 50
2017
Q2
$1.69M Sell
2,089
-164
-7% -$114K 0.36% 39
2017
Q1
$1.39M Sell
2,253
-60
-3% -$36.5K 0.3% 40
2016
Q4
$1.24M Hold
2,313
0.27% 44
2016
Q3
$1.2M Hold
2,313
0.28% 42
2016
Q2
$949K Hold
2,313
0.2% 46
2016
Q1
$1.23M Sell
2,313
-40
-2% -$19.9K 0.27% 39
2015
Q4
$1.79M Sell
2,353
-320
-12% -$212K 0.31% 40
2015
Q3
$1.47M Sell
2,673
-280
-9% -$170K 0.23% 43
2015
Q2
$1.74M Sell
2,953
-247
-8% -$144K 0.26% 46
2015
Q1
$2.51M Hold
3,200
0.41% 38
2014
Q4
$2.19M Buy
+3,200
New +$2.06M 0.44% 33

Other funds holding KYNB

Overbrook Management Corp's KYNB Position: Q3 2022 in Review

Overbrook Management Corp sold out of Kyntra Bio (KYNB) in Q3 2022, closing a stake of 415 shares — an estimated $110K sold.

Overbrook Management Corp first reported a position in KYNB in Q4 2014 and held it in 31 quarters. The position peaked at $2.51M in Q1 2015. 152 funds tracked by Wall St. Rank hold KYNB as of Q3 2022.

  • Overbrook Management Corp reported no remaining Kyntra Bio position as of Q3 2022 after selling out during the quarter.
  • Overbrook Management Corp sold 415 Kyntra Bio shares in Q3 2022, an estimated $110K.
  • Overbrook Management Corp first reported a position in Kyntra Bio in Q4 2014 and held it in 31 quarters.
  • Overbrook Management Corp's Kyntra Bio position peaked at $2.51M in Q1 2015.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2022.

Based on Overbrook Management Corp's 13F filing for Q3 2022, filed 10 Nov 2022.